In the past week, SLS stock has gone up by 1.51%, with a monthly gain of 9.64% and a quarterly plunge of -17.26%. The volatility ratio for the week is 6.95%, and the volatility levels for the last 30 days are 8.77% for SELLAS Life Sciences Group Inc The simple moving average for the last 20 days is -2.33% for SLS stock, with a simple moving average of -19.65% for the last 200 days.
Is It Worth Investing in SELLAS Life Sciences Group Inc (NASDAQ: SLS) Right Now?
Moreover, the 36-month beta value for SLS is 2.38. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SLS is 68.75M and currently, short sellers hold a 11.60% of that float. On January 23, 2025, SLS’s average trading volume was 1.29M shares.
SLS) stock’s latest price update
SELLAS Life Sciences Group Inc (NASDAQ: SLS) has seen a decline in its stock price by -13.64 in relation to its previous close of 1.14. However, the company has experienced a 1.51% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-23 that – REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical Trial Without Modification –
Analysts’ Opinion of SLS
Many brokerage firms have already submitted their reports for SLS stocks, with Cantor Fitzgerald repeating the rating for SLS by listing it as a “Overweight.” The predicted price for SLS in the upcoming period, according to Cantor Fitzgerald is $18 based on the research report published on July 21, 2021 of the previous year 2021.
H.C. Wainwright gave a rating of “Buy” to SLS, setting the target price at $11 in the report published on April 02nd of the previous year.
SLS Trading at -8.17% from the 50-Day Moving Average
After a stumble in the market that brought SLS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.76% of loss for the given period.
Volatility was left at 8.77%, however, over the last 30 days, the volatility rate increased by 6.95%, as shares surge +7.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.50% lower at present.
During the last 5 trading sessions, SLS fell by -1.33%, which changed the moving average for the period of 200-days by -28.58% in comparison to the 20-day moving average, which settled at $1.0066. In addition, SELLAS Life Sciences Group Inc saw -5.33% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SLS
The total capital return value is set at -2.06. Equity return is now at value -535.10, with -186.64 for asset returns.
Based on SELLAS Life Sciences Group Inc (SLS), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -57.42.
Currently, EBITDA for the company is 0.53 million with net debt to EBITDA at 1.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.26.
Conclusion
To wrap up, the performance of SELLAS Life Sciences Group Inc (SLS) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
